# Timesbole

> Timesbole is a VC fund in Shenzhen backing Manufacturing and Health Care. See 61 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Shenzhen, China
- Total investments: 61
- Last investment: Aug 2026
- Lead investor: 34%
- Last fund: Jan 2021
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/%E6%B7%B1%E5%9C%B3%E5%B8%82%E6%97%B6%E4%BB%A3%E4%BC%AF%E4%B9%90%E5%88%9B%E4%B8%9A%E6%8A%95%E8%B5%84%E7%AE%A1%E7%90%86%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8/about/
- Website: http://www.timesbole.cn/

Timesbole is a VC fund in Shenzhen focused on Manufacturing and Health Care. Times Bole Venture Capital Management Co., Ltd., established in Shenzhen in 2011, is a local M&A investment and industrial upgrading expert. The company is committed to providing professional services to listed companies, local governments, investors and project companies, to achieve the core of others, to create social incremental wealth astheir mission, create value and grow together.

## Contacts

5 contacts available for Timesbole. Shizune tracks 4 team members at Timesbole. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/timesbole?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Manufacturing | 21 | 34% |
| Health Care | 11 | 18% |
| Electronics | 9 | 15% |
| Medical | 8 | 13% |
| Automotive | 5 | 8% |

71 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 12 | 20% |
| Post-IPO Equity | 11 | 18% |
| Seed | 9 | 15% |
| Angel | 9 | 15% |
| Funding Round | 8 | 13% |

10 stages tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Bo Zhou | Chief Health Strategy Investment Officer | 0 | https://shizune.co/investors/profile/bo-zhou |
| Guoyun Jiang | President | 1 | https://shizune.co/investors/profile/guoyun-jiang |
| Liu Xiayue | senior vice president | 1 | https://shizune.co/investors/profile/liu-xiayue |
| Xiaolong Li | Chief Strategic Investment Officer | 0 | https://shizune.co/investors/profile/xiaolong-li-0568 |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Yilanke | Yilanke develops flexible interconnection equipment and multi-port energy router products focusing on the industrial and commercial modular optical storage systems. Yilanke provides safe and reliable solutions in the field of smart grid and new energy through innovative product design and advanced control technology. products, solutions andservices. |  | Series A | Aug 10, 2026 |  |
| Galaxea AI | Xinghaitu is an intelligent robot technology company that specializes in the development of humanoid robots with embodied intelligence. | $290.4M | Series B | Apr 02, 2026 |  |
| Feiyu Technology | Feiyu Technology focusing on solving the pain points and problems of high-altitude and high-risk operation scenarios in the energy industry. |  | Seed | Feb 15, 2026 |  |
| Qixing Fengtai | Qixing Fengtai is a battery component R&D company. |  | Seed | Feb 03, 2026 |  |
| Astribot | Astribot is a developer of consumer humanoid robots and integrated bionic robots. |  | Series A | Nov 18, 2025 |  |
| Horen | Horen is an IoT-driven packaging company for recyclable logistics. Every action that HOREN takes it one step closer to highly efficient circulation. | $18.1M | Series F | Jul 21, 2025 |  |
| Bytorent | Bytorent Provide professional risk assessment, design and customization of the overall safety protection system for automated production lines. Bytorent's goal is to continuously improve product functions and applications, solve safety problems in industrial production, and hope to more widely embed safety genes into domestic sensor andcontrol systems to achieve inherent safety. | $1.4M | Seed | Apr 20, 2025 |  |
| Yuanjian Ruishi Technology | Yuanjian Ruishi Technology solve the problem of unbalanced medical resources and bring good news to more eye health patients. | $1.4M | Angel | Mar 17, 2025 |  |
| DeyeeMed | DeyeeMed is a globally recognized professional artificial intelligence medical robot company that combines R&D, manufacture, sales, and service training. |  | Series A | Dec 06, 2024 |  |
| SoarWhale | SoarWhale operates as an automotive electronics component manufacturer for new energy vehicles. | $14M | Series C | Nov 07, 2024 |  |

10 of 61 investments shown.

## Co-investors
- [Fortune Venture Capital](https://shizune.co/investors/profile/fortune-venture-capital) — VC Fund, 2 deals together
- [Ant Group](https://shizune.co/investors/profile/ant-group) — VC Fund, 1 deal together
- [ASBV](https://shizune.co/investors/profile/asbv) — VC Fund, 1 deal together
- [Aviation Development Fund](https://shizune.co/investors/profile/aviation-development-fund) — VC Fund, 1 deal together
- [Beijing Financial Street Capital Operation Center](https://shizune.co/investors/profile/beijing-financial-street-capital-operation-center) — VC Fund, 1 deal together
- [Beijing Science and Technology Innovation Fund](https://shizune.co/investors/profile/beijing-science-and-technology-innovation-fund) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Timesbole invest in?

Timesbole invests primarily in Manufacturing, Health Care and Electronics startups, most often at Series A and Post-IPO Equity stage. Most of the 61 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Timesbole?

Public channels for Timesbole include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Timesbole?

The team at Timesbole includes Bo Zhou (Chief Health Strategy Investment Officer), Guoyun Jiang (President) and Liu Xiayue (senior vice president). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co